Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ascentage Pharma Announces Clinical Trial Agreement to Evaluate the Combination of Lisaftoclax (APG-2575) and the CDK4/6 Inhibitor IBRANCE® (Palbociclib) in Metastatic ER+/HER2- Breast Cancer
2021-11-08 21:47
Farmmi Announces Latest Multi-Product Sales Win
2021-11-08 21:00
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program
2021-11-08 08:10
PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline
2021-11-05 20:37
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting
2021-11-04 21:05
I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma at ASH 2021
2021-11-04 21:00
Taizhou, China: Building a Famous Chinese Medical City with Efforts
2021-11-04 20:16
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases
2021-11-04 19:30
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX
2021-11-03 22:00
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease
2021-11-03 21:00
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021
2021-11-03 15:00
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join
2021-11-03 12:28
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters
2021-11-02 21:00
GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center
2021-11-02 19:30
New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA
2021-11-02 09:00
Invetech Named Victorian Top Exporter of the Year
2021-10-30 05:35
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
2021-10-29 19:15
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81%
2021-10-29 17:17
Appendix 4C - Q1 FY22 Quarterly Cash Flow Report
2021-10-29 14:50
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology.
2021-10-28 21:00
1
96
97
98
99
100
222